Endourologic treatment of upper urinary tract transitional cell carcinoma
Michael C Ost, Brian A VanderBrink, Benjamin R Lee and Arthur D Smith*
Correspondence *Department of Urology, Long Island Jewish Medical Center, New Hyde Park, NY 11040–1496, USA
Email asmith@lij.edu
Developments in endourologic procedures now mean that the majority of patients with upper tract transitional cell carcinoma (UTTCC) can be offered minimally invasive treatments. Michael Ost and colleagues review the different procedures and adjuvant treatments available, and their suitability for patients with UTTCC.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$32 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
RESEARCH
Impact of the 1998 World Health Organization/International Society of Urological Pathology classification system for urothelial neoplasms of the kidneyModern Pathology Original Article